Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Multiple Myeloma × daratumumab × Clear all

Status

Active not recruiting 54 Completed 47 Recruiting 40 Terminated 14 Not yet recruiting 14 Unknown 8 Withdrawn 5 Suspended 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

talquetamab 1 pomalidomide 1 daratumumab 1 carfilzomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02477891 2019-01-15

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Janssen Research & Development, LLC

Approved for marketing

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡